- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/02 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
Patent holdings for IPC class C07D 261/02
Total number of patents in this class: 115
10-year publication summary
|
7
|
4
|
6
|
3
|
9
|
8
|
3
|
8
|
7
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Participations AG | 1516 |
7 |
| Syngenta Crop Protection AG | 6710 |
7 |
| Enanta Pharmaceuticals, Inc. | 421 |
5 |
| Theravance Biopharma R&D IP, LLC | 362 |
5 |
| Syngenta Crop Protection, LLC | 190 |
3 |
| Syngenta Limited | 426 |
3 |
| Medshine Discovery Inc. | 588 |
3 |
| Paratek Pharmaceuticals, Inc. | 105 |
3 |
| Bristol-myers Squibb Company | 4751 |
2 |
| Abbvie Inc. | 1824 |
2 |
| Denali Therapeutics Inc. | 271 |
2 |
| Genzyme Corporation | 1367 |
2 |
| Infinity Discovery, Inc. | 14 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 659 |
2 |
| Kissei Pharmaceutical Co., Ltd. | 177 |
2 |
| National Institute of Biological Sciences, Beijing | 101 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| Nuvalent, Inc. | 89 |
2 |
| Merck Sharp & Dohme LLC | 3736 |
2 |
| Advancion Corporation | 122 |
2 |
| Other owners | 55 |